Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2014; 20(4): 1067-1073
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.1067
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.1067
Table 4 Grade 1-4 toxicities n (%)
| Toxicity | Grade 1-2 | Grade 3-4 |
| Nausea | 13 (72.2) | 2 (11.1) |
| Vomiting | 5 (27.8) | 1 (5.6) |
| Diarrhea | 2 (11.1) | 0 |
| Stomatitis | 3 (16.7) | 0 |
| Anorexia | 13 (72.2) | 2 (11.1) |
| Fatigue | 13 (72.2) | 0 |
| Weight loss | 7 (38.9) | 0 |
| HFS | 3 (16.7) | 0 |
| Esophagitis | 0 | 1 (5.6) |
| Leukopenia | 14 (77.8) | 2 (11.1) |
| Neutropenia | 3 (16.7) | 1 (5.6) |
| Anemia | 3 (16.7) | 0 |
| Thrombocytopenia | 5 (27.8) | 0 |
| ALT/AST | 0 | 0 |
| Renal | 0 | 0 |
- Citation: Wang X, Jin J, Li YX, Ren H, Fang H, Wang SL, Liu YP, Wang WH, Yu ZH, Song YW, Liu XF. Phase I study of postoperative radiotherapy combined with capecitabine for gastric cancer. World J Gastroenterol 2014; 20(4): 1067-1073
- URL: https://www.wjgnet.com/1007-9327/full/v20/i4/1067.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i4.1067